Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Breast Cancer Research and Treatment|June 6, 2019
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcomeCody Plasterer, Shirng-Wern Tsaih, Amy R Peck, et al.Breast Cancer Research and Treatment|July 17, 2023
Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapyLubna N Chaudhary, Julie M Jorns, Yunguang Sun, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2018
Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 SignalingThai H Tran, Fransiscus E Utama, Takahiro Sato, et al.Science Advances|September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancersYunguang Sun, Ning Yang, Fransiscus E Utama, et al.JCO Precision Oncology|January 18, 2023
High PD-L2 Predicts Early Recurrence of ER-Positive Breast CancerInna Chervoneva, Amy R Peck, Yunguang Sun, et al.Journal of the American Heart Association|February 15, 2023
Collagen-Specific HSP47+ Myofibroblasts and CD163+ Macrophages Identify Profibrotic Phenotypes in Deceased Hearts With SARS-CoV-2 InfectionsAndrii Puzyrenko, Elizabeth R Jacobs, Nathan Padilla, et al.Oncogene|April 24, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.Research Square|January 30, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.Pageof 6